These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24890620)

  • 21. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.
    Niro GA; Ciancio A; Tillman HL; Lagget M; Olivero A; Perri F; Fontana R; Little N; Campbell F; Smedile A; Manns MP; Andriulli A; Rizzetto M
    Aliment Pharmacol Ther; 2005 Aug; 22(3):227-32. PubMed ID: 16091060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
    Mederacke I; Yurdaydin C; Dalekos GN; Bremer B; Erhardt A; Cakaloglu Y; Yalcin K; Gurel S; Zeuzem S; Zachou K; Bozkaya H; Dienes HP; Manns MP; Wedemeyer H;
    Antivir Ther; 2012; 17(2):305-12. PubMed ID: 22293066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Delta hepatitis].
    Matsuda S; Okita K
    Ryoikibetsu Shokogun Shirizu; 1995; (7):127-30. PubMed ID: 8749435
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection.
    Aziz S; Rajper J; Noor-ul-Ain W; Mehnaz A; Masroor M; Chang MH
    J Coll Physicians Surg Pak; 2011 Dec; 21(12):735-40. PubMed ID: 22166693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of IgM anti-HD during interferon therapy.
    Marinucci G; Hassan G; Di Giacomo C; Dato A; Barlattani A; Costa F
    Prog Clin Biol Res; 1993; 382():311-8. PubMed ID: 8502696
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic hepatitis D: New advances, old challenges.
    Farci P
    Hepatology; 2006 Sep; 44(3):536-9. PubMed ID: 16941704
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
    Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of delta hepatitis.
    Gunsar F
    Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: the potential success of long-term therapy of chronic delta hepatitis with peginterferon alfa.
    Maraolo AE; Minervini F; Tosone G
    Aliment Pharmacol Ther; 2015 Mar; 41(6):595. PubMed ID: 25659214
    [No Abstract]   [Full Text] [Related]  

  • 30. Two-year interferon therapy with or without ribavirin in chronic delta hepatitis.
    Gunsar F; Akarca US; Ersoz G; Kobak AC; Karasu Z; Yuce G; Ilter T; Batur Y
    Antivir Ther; 2005; 10(6):721-6. PubMed ID: 16218171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging concepts for the treatment of hepatitis delta.
    Elazar M; Glenn JS
    Curr Opin Virol; 2017 Jun; 24():55-59. PubMed ID: 28475945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha interferon therapy of chronic delta hepatitis: a pilot study.
    Di Bisceglie AM; Negro F; Smedile A; Bergmann K; Hoofnagle JH
    Prog Clin Biol Res; 1991; 364():393-7. PubMed ID: 2020714
    [No Abstract]   [Full Text] [Related]  

  • 33. Weight-based dosing regimen of peg-interferon α-2b for chronic hepatitis delta: a multicenter Romanian trial.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Constantinescu I; Caruntu F; Sporea I; Grigorescu M
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):377-82. PubMed ID: 22187703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peginterferon plus adefovir versus either drug alone for hepatitis delta.
    Wedemeyer H; Yurdaydìn C; Dalekos GN; Erhardt A; Çakaloğlu Y; Değertekin H; Gürel S; Zeuzem S; Zachou K; Bozkaya H; Koch A; Bock T; Dienes HP; Manns MP;
    N Engl J Med; 2011 Jan; 364(4):322-31. PubMed ID: 21268724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials.
    Lamers MH; Kirgiz ÖÖ; Heidrich B; Wedemeyer H; Drenth JP
    Antivir Ther; 2012; 17(6):1029-37. PubMed ID: 22892440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis: antiviral treatment for hepatitis D.
    Triantos C; Kalafateli M; Nikolopoulou V; Burroughs A
    Aliment Pharmacol Ther; 2012 Mar; 35(6):663-73. PubMed ID: 22273482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis D virus: an update.
    Pascarella S; Negro F
    Liver Int; 2011 Jan; 31(1):7-21. PubMed ID: 20880077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comment on: 'interleukin-28 polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis'.
    Fernández-Rodríguez A; Jiménez-Sousa MÁ; Resino S
    Gene; 2013 Jun; 522(1):121. PubMed ID: 23506831
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience.
    Abbas Z; Memon MS; Mithani H; Jafri W; Hamid S
    Antivir Ther; 2014; 19(5):463-8. PubMed ID: 24423484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegylated interferon therapy of chronic hepatitis D: in need of revision.
    Rizzetto M; Smedile A
    Hepatology; 2015 Apr; 61(4):1109-11. PubMed ID: 25348580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.